UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 30,
Oragenics (AMEX:OGEN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Oragenics Charts.
Oragenics (AMEX:OGEN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Oragenics Charts.

Oragenics Inc News

Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Friday 19 April 2024 (2 weeks ago) • Business Wire
Oragenics, Inc. Files 10K and Provides Company Update
Monday 1 April 2024 (1 month ago) • Business Wire
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Monday 18 March 2024 (2 months ago) • Business Wire
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Tuesday 5 March 2024 (2 months ago) • Business Wire
Oragenics Announces Closing of Public Offering
Friday 1 March 2024 (2 months ago) • Business Wire
Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Oragenics Announces Pricing of Public Offering
Tuesday 27 February 2024 (2 months ago) • Business Wire
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Oragenics Announces Proposed Public Offering
Tuesday 27 February 2024 (2 months ago) • Business Wire

More Oragenics Inc News Articles